BioLife Solutions
BLFS
17 hedge funds and large institutions have $609K invested in BioLife Solutions in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
6% more funds holding
Funds holding: 16 → 17 (+1)
7% less capital invested
Capital invested by funds: $653K → $609K (-$44K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$22.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$14.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.17K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$219 |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$50 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
BLFS Hedge Fund Activity: Q2 2016 in Review
17 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2016, worth a combined $609K — down 6.7% from $653K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BLFS positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $22.5K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $2K sold.
- 17 institutional investors held BioLife Solutions (BLFS) as of Q2 2016, up from 16 in Q1 2016.
- Funds reported $609K of BioLife Solutions stock for Q2 2016, down 6.7% quarter-over-quarter.
- 4 funds opened new BioLife Solutions positions in Q2 2016 and 3 closed out, a net change of +1 holder.
- The largest BioLife Solutions buyer in Q2 2016 was Two Sigma Securities, an estimated $22.5K added.
- The largest BioLife Solutions seller in Q2 2016 was Tower Research Capital (TRC), an estimated $2K sold.
Based on aggregated 13F filings for Q2 2016.